Stephen J Kron Selected Research

Stephen J Kron Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 01/2004
6	Breast Neoplasms (Breast Cancer) 10/2019 - 08/2010
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2010 - 09/2005
3	Genomic Instability 01/2021 - 01/2019
3	Starvation 01/2017 - 07/2002
2	Neoplasm Metastasis (Metastasis) 10/2021 - 05/2012
2	Chromosomal Instability (Chromosome Stability) 01/2019 - 12/2002
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019 - 03/2011
2	Melanoma (Melanoma, Malignant) 01/2018 - 05/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2012 - 10/2010
2	Necrosis 03/2011 - 08/2010
1	Polyps 11/2021
1	Poisoning 01/2021
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2021
1	Pulmonary Edema 10/2019
1	Hypoxia (Hypoxemia) 03/2019
1	Bites and Stings (Sting) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2004
8	Pharmaceutical PreparationsIBA 01/2021 - 12/2005
8	Phosphotransferases (Kinase)IBA 01/2019 - 12/2002
6	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2019 - 08/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2010
4	Peptides (Polypeptides)IBA 02/2013 - 01/2004
3	EnzymesIBA 11/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2008
3	LigandsIBA 01/2019 - 11/2017
3	ChromatinIBA 01/2019 - 08/2010
3	ErbB Receptors (EGF Receptor)IBA 02/2013 - 10/2010
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2012 - 09/2005
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2012 - 08/2010
3	veliparibIBA 05/2012 - 08/2010
2	CytokinesIBA 10/2019 - 05/2012
2	Immune Checkpoint InhibitorsIBA 10/2019 - 11/2017
2	AntibodiesIBA 10/2019 - 01/2019
2	B7-H1 AntigenIBA 10/2019 - 12/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2019 - 12/2002
2	AntigensIBA 01/2019 - 01/2017
2	Therapeutic UsesIBA 01/2019 - 10/2016
2	VaccinesIBA 11/2017 - 01/2017
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 03/2011
2	Tyrosine Kinase InhibitorsIBA 02/2013 - 10/2010
2	NitrogenIBA 12/2012 - 07/2002
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2012 - 10/2010
2	Green Fluorescent ProteinsIBA 03/2011 - 08/2010
2	bcr-abl Fusion ProteinsIBA 10/2010 - 04/2008
2	Imatinib Mesylate (Gleevec)FDA Link 10/2010 - 04/2008
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	PolyphosphatesIBA 11/2021
1	PolymersIBA 11/2021
1	CationsIBA 11/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2021
1	Phosphates (Orthophosphate)IBA 11/2021
1	SenotherapeuticsIBA 10/2021
1	CamptothecinIBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	LipidsIBA 01/2021
1	PoisonsIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	CTLA-4 AntigenIBA 10/2019
1	cyclopropapyrroloindoleIBA 10/2019
1	Blood Proteins (Serum Proteins)IBA 10/2019
1	Interleukin-2 (IL2)IBA 10/2019
1	von Willebrand FactorIBA 10/2019
1	CollagenIBA 10/2019
1	Anti-Idiotypic AntibodiesIBA 10/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2019
1	Apoptosis Regulatory ProteinsIBA 01/2019
1	hexosaminidase CIBA 01/2019
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2019
1	AcetylglucosamineIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2019
1	InterferonsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	DNA-Activated Protein KinaseIBA 01/2019
1	HexosaminesIBA 01/2019
1	Mevalonic Acid (Mevalonate)IBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 12/2018
1	Drug CarriersIBA 12/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2018
1	Quinic Acid (Quinate)IBA 12/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2018
1	SelectinsIBA 12/2018
1	CyclinsIBA 01/2018
1	pitavastatin (itavastatin)FDA Link 01/2018
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	OligodeoxyribonucleotidesIBA 11/2017
1	Interferon-gamma (Interferon, gamma)IBA 11/2017

Therapy/Procedure

19	Therapeutics 10/2021 - 01/2008
10	Radiotherapy 03/2019 - 01/2004
7	Drug Therapy (Chemotherapy) 10/2021 - 12/2005
4	Immunotherapy 10/2019 - 05/2012
2	Image-Guided Radiotherapy 01/2018 - 10/2016